Argus上调西维斯健康目标价至91美元

Core Viewpoint - Argus Research has raised the target price for WestView Health from $80 to $91 while maintaining a "Buy" rating [1] Summary by Category Company Analysis - The target price adjustment reflects a positive outlook on WestView Health's performance and potential growth [1] Investment Recommendation - The "Buy" rating indicates confidence in the company's future prospects and suggests that it is a favorable investment opportunity [1]